Regulation of influenza virus replication by Wnt/β-catenin signaling

PLoS ONE

Volumn 13, Issue 1, 2018, Pages

  More, Sunil ^a   Yang, Xiaoyun ^a   Zhu, Zhengyu ^a   Bamunuarachchi, Gayan ^a   Guo, Yujie ^a   Huang, Chaoqun ^a   Bailey, Keith ^a   Metcalf, Jordan P ^a,b   Liu, Lin ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ICRT 14; LACTATE DEHYDROGENASE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VIRAL PROTEIN; WNT3A PROTEIN; VIRUS RNA;

2009 H1N1 INFLUENZA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL CYCLE REGULATION; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLUENZA; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA A VIRUS (H1N1); MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; VIRAL PLAQUE ASSAY; VIROGENESIS; VIRUS LOAD; VIRUS REPLICATION; WESTERN BLOTTING; WNT SIGNALING; A-549 CELL LINE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DOG; GENETICS; INFLUENZA A VIRUS; LUNG ALVEOLUS; MDCK CELL LINE; METABOLISM; PHYSIOLOGY; VIROLOGY;

A549 CELLS; ANIMALS; DOGS; HUMANS; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MALE; MICE; MICE, INBRED C57BL; PULMONARY ALVEOLI; RNA, VIRAL; VIRUS REPLICATION; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 85040372973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0191010     Document Type: Article

References (49)

1. Watanabe T, Kawakami E, Shoemaker JE, Lopes TJ, Matsuoka Y, Tomita Y, et al. (2014) Influenza virus-host interactome screen as a platform for antiviral drug development. Cell Host Microbe 16: 795–805. S1931-3128(14)00398-9 [pii]; https://doi.org/10.1016/j.chom.2014.11.002 PMID: 25464832
2. Kumar N, Xin ZT, Liang Y, Ly H, Liang Y (2008) NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol 82: 9880–9889. JVI.00909-08 [pii]; https://doi.org/10.1128/JVI.00909-08PMID: 18701591
3. Lamb RA, Krug RM (2003) Orthomyxoviridae:the viruses and their replicatoion. In: Lippincott-Raven. pp. 1487–1531.
4. Bouvier NM, Palese P (2008) The biology of influenza viruses. Vaccine 26 Suppl 4: D49–D53.
5. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428–433. https://doi.org/10.1038/nature01509 nature01509 [pii]. PMID: 12660783
6. Noah DL, Noah JW (2013) Adapting global influenza management strategies to address emerging viruses. Am J Physiol Lung Cell Mol Physiol 305: L108–L117. ajplung.00105.2013 [pii]; https://doi.org/10.1152/ajplung.00105.2013 PMID: 23709619
7. Kelso JK, Halder N, Milne GJ (2013) Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis. BMC Infect Dis 13: 81. 1471-2334-13-81 [pii]; https://doi.org/10.1186/1471-2334-13-81 PMID: 23398722
8. Hayden FG, Hay AJ (1992) Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 176: 119–130. PMID: 1600749
9. Aeffner F, Bratasz A, Flano E, Powell KA, Davis IC (2012) Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice. Am J Respir Cell Mol Biol 47: 543–551. rcmb.2012-0112OC [pii]; https://doi.org/10.1165/rcmb.2012-0112OC PMID: 22679275
10. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255–1267. S0092-8674(09)01565-7 [pii]; https://doi.org/10.1016/j.cell.2009.12.018 PMID: 20064372
11. Song L, Liu H, Gao S, Jiang W, Huang W (2010) Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 84: 8849–8860. JVI.00456-10 [pii]; https://doi.org/10.1128/JVI.00456-10 PMID: 20554777
12. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13: 11–26. nrc3419 [pii]; https://doi.org/10.1038/nrc3419 PMID: 23258168
13. Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, Evans S, et al. (2011) An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci U S A 108: 5954–5963. 1017496108 [pii]; https://doi.org/10.1073/pnas.1017496108PMID: 21393571
14. Weiser K, Barton M, Gershoony D, DasGupta R, Cardozo T (2013) HIV’s Nef interacts with beta-catenin of the Wnt signaling pathway in HEK293 cells. PLoS One 8: e77865. https://doi.org/10.1371/journal.pone.0077865 PONE-D-12-18047 [pii]. PMID: 24130899
15. Liu J, Wang Z, Tang J, Tang R, Shan X, Zhang W, et al. (2011) Hepatitis C virus core protein activates Wnt/beta-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line. Arch Virol 156: 1013–1023. https://doi.org/10.1007/s00705-011-0943-x PMID: 21340743
16. Street A, Macdonald A, McCormick C, Harris M (2005) Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 79: 5006–5016. 79/8/5006 [pii]; https://doi.org/10.1128/JVI.79.8.5006-5016.2005 PMID: 15795286
17. Kumar A, Zloza A, Moon RT, Watts J, Tenorio AR, Al-Harthi L (2008) Active beta-catenin signaling is an inhibitory pathway for human immunodeficiency virus replication in peripheral blood mononuclear cells. J Virol 82: 2813–2820. JVI.02498-07 [pii]; https://doi.org/10.1128/JVI.02498-07 PMID: 18199649
18. Narasipura SD, Henderson LJ, Fu SW, Chen L, Kashanchi F, Al-Harthi L (2012) Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 86: 1911–1921. JVI.06266-11 [pii]; https://doi.org/10.1128/JVI.06266-11 PMID: 22156527
19. Dandekar S, Romanos-Sirakis E, Pais F, Bhatla T, Jones C, Bourgeois W, et al. (2014) Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia. Br J Haematol 167: 87–99. https://doi.org/10.1111/bjh.13011 PMID: 24995804
20. Wang Y, Huang C, Reddy CN, Bhaskaran M, Weng T, Guo Y, et al. (2013) miR-375 regulates rat alveolar epithelial cell trans-differentiation by inhibiting Wnt/beta-catenin pathway. Nucleic Acids Res 41: 3833–3844. gks1460 [pii]; https://doi.org/10.1093/nar/gks1460 PMID: 23396279
21. Samji T (2009) Influenza A: understanding the viral life cycle. Yale J Biol Med 82: 153–159. PMID: 20027280
22. Wray SK, Gilbert BE, Noall MW, Knight V (1985) Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res 5: 29–37. PMID: 3985606
23. Garcia-Sastre A (2011) Induction and evasion of type I interferon responses by influenza viruses. Virus Res 162: 12–18. S0168-1702(11)00411-4 [pii]; https://doi.org/10.1016/j.virusres.2011.10.017 PMID: 22027189
24. Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, et al. (1998) Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc Natl Acad Sci U S A 95: 9837–9842. PMID: 9707562
25. Emeny JM, Morgan MJ (1979) Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol 43: 247–252. https://doi.org/10.1099/0022-1317-43-1-247 PMID: 113494
26. Mishra A, Guo Y, Zhang L, More S, Weng T, Chintagari NR, et al. (2016) A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration during Acute Lung Injury. J Immunol 197: 2828–2837. jimmunol.1501041 [pii]; https://doi.org/10.4049/jimmunol.1501041 PMID: 27559050
27. Bhaskaran M, Kolliputi N, Wang Y, Gou D, Chintagari NR, Liu L (2007) Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway. J Biol Chem 282: 3968–3976. M609060200 [pii]; https://doi.org/10.1074/jbc.M609060200 PMID: 17158884
28. Arias-Romero LE, Villamar-Cruz O, Huang M, Hoeflich KP, Chernoff J (2013) Pak1 kinase links ErbB2 to beta-catenin in transformation of breast epithelial cells. Cancer Res 73: 3671–3682. 0008-5472. CAN-12-4453 [pii]; https://doi.org/10.1158/0008-5472.CAN-12-4453 PMID: 23576562
29. Nimmerjahn F, Dudziak D, Dirmeier U, Hobom G, Riedel A, Schlee M, Staudt LM, et al. (2004) Active NF-kappaB signalling is a prerequisite for influenza virus infection. J Gen Virol 85: 2347–2356. https://doi.org/10.1099/vir.0.79958-0 85/8/2347 [pii]. PMID: 15269376
30. Wurzer WJ, Ehrhardt C, Pleschka S, Berberich-Siebelt F, Wolff T, Walczak H, et al. (2004) NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem 279: 30931–30937. https://doi.org/10.1074/jbc.M403258200 M403258200 [pii]. PMID: 15143063
31. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, et al. (2001) Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 3: 301–305. https://doi.org/10.1038/35060098 PMID: 11231581
32. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103: 14194–14199. 0606109103 [pii]; https://doi.org/10.1073/pnas.0606109103 PMID: 16963558
33. Lu Y, Wambach M, Katze MG, Krug RM (1995) Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214: 222–228. S0042682285799370 [pii]. PMID: 8525619
34. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783–801. S0092-8674(06)00190-5 [pii]; https://doi.org/10.1016/j.cell.2006.02.015 PMID: 16497588
35. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, et al. (2009) Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5: 439–449. S1931-3128(09)00107-3 [pii]; https://doi.org/10.1016/j.chom.2009.04.006 PMID: 19454348
36. Hillesheim A, Nordhoff C, Boergeling Y, Ludwig S, Wixler V (2014) beta-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-kappaB signaling. Cell Commun Signal 12: 29. 1478-811X-12-29 [pii]; https://doi.org/10.1186/1478-811X-12-29 PMID: 24767605
37. Ma B, Hottiger MO (2016) Crosstalk between Wnt/beta-Catenin and NF-kappaB Signaling Pathway during Inflammation. Front Immunol 7: 378. https://doi.org/10.3389/fimmu.2016.00378 PMID: 27713747
38. Niehrs C, Acebron SP (2012) Mitotic and mitogenic Wnt signalling. EMBO J 31: 2705–2713. emboj2012124 [pii]; https://doi.org/10.1038/emboj.2012.124 PMID: 22617425
39. Hopkins K, Cherry S (2013) Bunyaviral cap-snatching vs. decapping: recycling cell cycle mRNAs. Cell Cycle 12: 3711–3712. 26878 [pii]; https://doi.org/10.4161/cc.26878 PMID: 24145225
40. Cawood R, Harrison SM, Dove BK, Reed ML, Hiscox JA (2007) Cell cycle dependent nucleolar localization of the coronavirus nucleocapsid protein. Cell Cycle 6: 863–867. 4032 [pii]; https://doi.org/10.4161/cc.6.7.4032 PMID: 17426449
41. Baril M, Es-Saad S, Chatel-Chaix L, Fink K, Pham T, Raymond VA, et al. (2013) Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog 9: e1003416. https://doi.org/10.1371/journal.ppat.1003416 PPATHOGENS-D-12-03069 [pii]. PMID: 23785285
42. Hillesheim A, Nordhoff C, Boergeling Y, Ludwig S, Wixler V (2014) beta-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-kappaB signaling. Cell Commun Signal 12: 29. 1478-811X-12-29 [pii]; https://doi.org/10.1186/1478-811X-12-29 PMID: 24767605
43. Tanaka M, Yamazaki Y, Kanno Y, Igarashi K, Aisaki K, Kanno J, et al. (2014) Ewing’s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors. J Clin Invest 124: 3061–3074. 72399 [pii]; https://doi.org/10.1172/JCI72399 PMID: 24911143
44. Govorkova EA, Webster RG (2010) Combination chemotherapy for influenza. Viruses 2: 1510–1529. https://doi.org/10.3390/v2081510 viruses-02-01510 [pii]. PMID: 21994692
45. Reed L, Muench H (1938) A simple method of estimating fifty percent endpoints. American Journal of Epidemiology 27: 493–497.
46. Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y (2011) Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses. Antimicrob Agents Chemother 55: 5553–5559. AAC.00725-11 [pii]; https://doi.org/10.1128/AAC.00725-11 PMID: 21930873
47. Shirey KA, Lai W, Scott AJ, Lipsky M, Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J, Chen WH, Ernst RK, Rossignol DP, Gusovsky F, Blanco JC, Vogel SN (2013) The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497: 498–502. nature12118 [pii]; https://doi.org/10.1038/nature12118 PMID: 23636320
48. Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y, et al. (2014) Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J Virol 88: 10228–10243. JVI.01774-14 [pii]; https://doi.org/10.1128/JVI.01774-14 PMID: 24965445
49. Lutz A, Dyall J, Olivo PD, Pekosz A (2005) Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J Virol Methods 126: 13–20. S0166-0934(05)00029-7 [pii]; https://doi.org/10.1016/j.jviromet.2005.01.016 [doi] PMID: 15847914